Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Filings indexed 512 across all filing types
Latest filing 2026-05-28 Capital/Financing Update
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
424B3
Capital/Financing Update Classification · 90% confidence The document is a full SEC prospectus (Form 424B3) relating to the registration and resale of common stock, detailing conversion shares, terms of the private placement, use of proceeds, and plan of distribution. This is a financing document for capital raising/structure rather than a periodic report, proxy statement, or management commentary. It falls under the Capital/Financing Update category.
2026-05-28 English
S-3
Capital/Financing Update Classification · 82% confidence The document is a Form S-3 registration statement and prospectus filed with the SEC for resale of common stock by selling stockholders. It outlines the terms of the securities offering and registration under the Securities Act, which constitutes a financing activity (capital structure update) rather than a governance, annual report, or equity issuance announcement. Therefore, it best fits the “Capital/Financing Update” category (CAP).
2026-05-18 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-18 English
10-K - ENvue Medical, Inc. (0001326706) (Filer)
Annual Report FY 2024
2026-04-15 English
4 Filing
Director's Dealing
2026-02-11 English
3 Filing
Director's Dealing
2026-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.